Sorrento Therapeutics (LTS:0L85) Change In Inventory : $0.03 Mil (TTM As of Jun. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Sorrento Therapeutics Change In Inventory?

Sorrento Therapeutics's change in inventory for the quarter that ended in Jun. 2023 was $-0.50 Mil. It means Sorrento Therapeutics's inventory increased by $0.50 Mil from Mar. 2023 to Jun. 2023 .

Sorrento Therapeutics's change in inventory for the fiscal year that ended in Dec. 2022 was $-9.51 Mil. It means Sorrento Therapeutics's inventory increased by $9.51 Mil from Dec. 2021 to Dec. 2022 .

Sorrento Therapeutics's Total Inventories for the quarter that ended in Jun. 2023 was $9.65 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Sorrento Therapeutics's Days Inventory for the quarter that ended in Jun. 2023 was 113.13.

Inventory Turnover measures how fast the company turns over its inventory within a year. Sorrento Therapeutics's Inventory Turnover for the quarter that ended in Jun. 2023 was 0.81.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Sorrento Therapeutics's Inventory-to-Revenue for the quarter that ended in Jun. 2023 was 0.70.

Sorrento Therapeutics Change In Inventory Historical Data

The historical data trend for Sorrento Therapeutics's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sorrento Therapeutics Change In Inventory Chart

Sorrento Therapeutics Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Change In Inventory

Get a 7-Day Free Trial

1.53

-6.28

-9.51

Sorrento Therapeutics Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Change In Inventory	Get a 7-Day Free Trial															-5.40	6.88	-5.01	-1.33	-0.50

Sorrento Therapeutics Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.03 Mil.

Sorrento Therapeutics (LTS:0L85) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Sorrento Therapeutics's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	10.4795	/	8.453	*	365 / 4
	=	113.13

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Sorrento Therapeutics's Inventory Turnover for the quarter that ended in Jun. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	8.453	/	10.4795
	=	0.81

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Sorrento Therapeutics's Inventory to Revenue for the quarter that ended in Jun. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	10.4795	/	15.025
	=	0.70

Sorrento Therapeutics Change In Inventory Related Terms

Thank you for viewing the detailed overview of Sorrento Therapeutics's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Sorrento Therapeutics (LTS:0L85) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sorrento Therapeutics Inc (LTS:0L85) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

SRNEQ:USA

Address

4955 Directors Place, San Diego, CA, USA, 92121

Website

https://www.sorrentotherapeutics.com

Sorrento Therapeutics Inc is a clinical and commercial-stage biopharmaceutical company developing a portfolio of next-generation treatments for three major therapeutic areas: cancer, infectious disease, and pain. Its multimodal, multipronged approach to fighting cancer is made possible by its extensive immuno-oncology platforms, including key assets such as fully human antibodies (G-MAB library), immuno-cellular therapies (DAR-T), antibody-drug conjugates (ADCs), and oncolytic virus (Seprehvec). Sorrento is also developing potential antiviral therapies and vaccines against coronaviruses, including COVI-AMG, COVIDROPS, COVISHIELD, FUJOVEE (Abivertinib), and OQORY (Covi-MSC), and diagnostic test solutions, including COVITRACK and COVIMARK.

Sorrento Therapeutics (LTS:0L85) Headlines

No Headlines